Literature DB >> 4213872

Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.

M L Tapper, D Armstrong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4213872     DOI: 10.1093/infdis/130.supplement.s14

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.

Authors:  Y Van Laethem; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  Aberrant form of Pseudomonas aeruginosa in sputum and cerebrospinal fluid causing infection in a compromised patient.

Authors:  J Middleton; H Chmel
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

3.  Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.

Authors:  T Meshulam; H A Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-04       Impact factor: 3.267

4.  Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Authors:  C L Pierson; A G Johnson; I Feller
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia.

Authors:  L Harvath; B R Andersen
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors:  W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

8.  Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

Authors:  M Lynn; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem.

Authors:  J A Korvick; J W Marsh; T E Starzl; V L Yu
Journal:  Surgery       Date:  1991-01       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.